Moscow police say 250 people take part in protest rallyWorld April 29, 16:29
Diplomat calls US’ allegations about isolation of Russia in UN 'strange'Russian Politics & Diplomacy April 28, 20:58
Experts say Russian hackers strongly demonized in USRussian Politics & Diplomacy April 28, 20:35
Ferrari drivers clock best time in Practice Two of Russia F1 GP in SochiSport April 28, 19:54
Red Bull’s advisor Marko says Kvyat to possibly remain with Toro Rosso next yearSport April 28, 19:16
Pope Francis blesses pregnant TASS correspondent en route to EgyptWorld April 28, 18:55
Russian diplomat says use of military force against North Korean unacceptable, dangerousRussian Politics & Diplomacy April 28, 18:45
UN chief calls for lowering risk of miscalculation concerning North Korea issueWorld April 28, 18:15
Moscow deeply regrets Montenegro’s decision to join NATORussian Politics & Diplomacy April 28, 18:07
SEOUL, July 23. /TASS/. As many as 12 patients with the Middle East Respiratory Syndrome coronavirus (MERS-CoV) are still undergoing medical treatment at hospitals in South Korea, the country’s ministry of health and welfare said on Thursday.
Eleven of them have no virus in blood tests, but they have to stay in hospital due to after-effects.
No new MERS cases have been reported from South Korea for 18 days. In case this tendency stays, the MERS outbreak will be officially announced over on August 2.
As many as 186 cases have been registered since May 20. The overall death toll from the disease in South Korea is 35.
The first MERS case in South Korea was registered on May 20.
Middle East respiratory syndrome (MERS) is a viral respiratory infection caused by the newly identified MERS-coronavirus (MERS-CoV) that is new to humans. It was first reported in Saudi Arabia in 2012 and has since spread to other countries, including Jordan, Qatar, the United Arab Emirates, Tunisia, the United Kingdom, Germany, Italy, France - 23 in all, where more than 1,100 MERS cases have been officially registered, of which 40% ended in patients’ deaths.
Most MERS-CoV patients develop severe acute respiratory illness, including fever, cough, and trouble breathing. About 3-4 out of every 10 MERS patients die. MERS-CoV is spread through close contact.